Mizuho raised their price objective on Abbott Laboratories from $115.00 to $130.00 and gave the stock a “neutral” rating in a research note on Thursday, October 17th. Argus raised shares of ...

Healthcare product and device company Abbott Laboratories (NYSE:ABT) in Q4 CY2024, with sales up 7.2% year on year to $10.97 ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Reveal insider sentiment with alternative data that tracks buy and sell trades made by top managers and company directors.

The peers of Abbott India Ltd are Sun Pharmaceuticals Industries Ltd, Divis Laboratories Ltd ... The highest price of Abbott India Ltd stock is ₹30,668.00 in the last 52-week.

Nasdaq provides Price/Earnings Ratio (or PE Ratio) and PEG ratio for stock evaluation. Financial analysts and individual investors use PE Ratio and PEG ratios to determine the financial ...

Shares of Abbott Laboratories ABT rose 2.29% to $132.06 Wednesday, on what proved to be an all-around positive trading ...

Using the 2 Stage Free Cash Flow to Equity, Abbott Laboratories fair value estimate is US$152 With US$129 share price, Abbott Laboratories appears to be trading close to its estimated fair value ...

Drugmaker Abbott India reported a jump in third-quarter profit on Wednesday, helped by strong demand for its gastrointestinal and heart disease medications, sending shares higher. The ...

In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other stocks discussed by ...

In his latest remarks, Cramer wondered how much hot money was in Abbott Laboratories (NYSE:ABT) stock at a time when tech was crashing: “Well look at Abbott Labs then. Oh my god. Are you serious?